FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Koichi Yokogawa

Research Profile

Living Beings

Chemicals & Drugs

Concepts & Ideas

Anatomy

Livers
Brain

Procedures

Co-author Network

Publications

TOP 3
Junko Ishizaki; Akiko Fukaishi; Chie Fukuwa; Satoko Yamazaki; Mayu Tabata; Takuya Ishida; Yukio Suga; Kunizo Arai; Koichi Yokogawa; Ken-ichi Miyamoto
Evaluation of selective competitive binding of basic drugs to alpha1-acid glycoprotein variants.
Junko Ishizaki; Yoshihiro Waki; Tatsuo Takahashi-Nishioka; Koichi Yokogawa; Ken-Ichi Miyamoto
Selective drug delivery to bone using acidic oligopeptides.
Masami Kawahara; Yuri Takahashi; Koutarou Takazawa; Hiroyuki Tsuchiya; Katsuro Tomita; Koichi Yokogawa; Ken-ichi Miyamoto
Caffeine dose-dependently potentiates the antitumor effect of cisplatin on osteosarcomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Koichi Yokogawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Junko Ishizaki; Akiko Fukaishi; Chie Fukuwa; Satoko Yamazaki; Mayu Tabata; Takuya Ishida; Yukio Suga; Kunizo Arai; Koichi Yokogawa; Ken-ichi Miyamoto
Evaluation of selective competitive binding of basic drugs to alpha1-acid glycoprotein variants.
Biological & pharmaceutical bulletin 2010;33(1):95-9.
2009: Junko Ishizaki; Yoshihiro Waki; Tatsuo Takahashi-Nishioka; Koichi Yokogawa; Ken-Ichi Miyamoto
Selective drug delivery to bone using acidic oligopeptides.
Journal of bone and mineral metabolism 2009;27(1):1-8.
2008: Masami Kawahara; Yuri Takahashi; Koutarou Takazawa; Hiroyuki Tsuchiya; Katsuro Tomita; Koichi Yokogawa; Ken-ichi Miyamoto
Caffeine dose-dependently potentiates the antitumor effect of cisplatin on osteosarcomas.
Anticancer research 2008;28(3A):1681-5.
2008: Junko Ishizaki; Satsuki Ito; Mingji Jin; Tsutomu Shimada; Tamae Ishigaki; Yukiko Harasawa; Koichi Yokogawa; Akiyoshi Takami; Shinji Nakao; Ken-Ichi Miyamoto
Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B.
Biopharmaceutics & drug disposition 2008;29(4):195-203.
2008: Hiroko Ohkawa; Chie Fukuwa; Naoto Matsuzawa-Nagata; Koichi Yokogawa; Kenji Omura; Ken-ichi Miyamoto
Soybean fat supplementation controls insulin resistance caused by fat-free total parenteral nutrition.
The Journal of pharmacy and pharmacology 2008;60(4):461-5.
2008: Tatsuo Takahashi-Nishioka; Koichi Yokogawa; Shunji Tomatsu; Masaaki Nomura; Shinjiro Kobayashi; Ken-Ichi Miyamoto
Targeted drug delivery to bone: pharmacokinetic and pharmacological properties of acidic oligopeptide-tagged drugs.
Current drug discovery technologies 2008;5(1):39-48.
2007: Phisit Khemawoot; Kousuke Nishino; Junko Ishizaki; Koichi Yokogawa; Ken-ichi Miyamoto
Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
European journal of pharmacology 2007;574(1):71-6.
2007: Phisit Khemawoot; Chiharu Maruyama; Hirotaka Tsukada; Hiroyo Noda; Junko Ishizaki; Koichi Yokogawa; Ken-ichi Miyamoto
Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride.
Biopharmaceutics & drug disposition 2007;28(6):331-8.
2007: Daisuke Ichimatsu; Masaaki Nomura; Seiji Nakamura; Shuzo Moritani; Koichi Yokogawa; Shinjiro Kobayashi; Tatsuo Nishioka; Ken-ichi Miyamoto
Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells.
Molecular carcinogenesis 2007;46(6):436-45.
2007: Koichi Yokogawa; Shoko Shimomura; Junko Ishizaki; Tsutomu Shimada; Chie Fukuwa; Masayuki Kawada; Tsunehisa Tsubokawa; Ken Yamamoto; Ken-ichi Miyamoto
Involvement of alpha1-acid glycoprotein in inter-individual variation of disposition kinetics of ropivacaine following epidural infusion in off-pump coronary artery bypass grafting.
The Journal of pharmacy and pharmacology 2007;59(1):67-73.
2007: Phisit Khemawoot; Koichi Yokogawa; Tsutomu Shimada; Ken-Ichi Miyamoto
Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats.
Biochemical pharmacology 2007;73(1):155-62.
2006: Mingji Jin; Tsutomu Shimada; Koichi Yokogawa; Masaaki Nomura; Junko Ishizaki; Yingshi Piao; Yukio Kato; Akira Tsuji; Ken-Ichi Miyamoto
Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice.
Biochemical pharmacology 2006;72(8):1042-50.
2006: Koichi Yokogawa; Katsuhiro Toshima; Kayo Yamoto; Tatsuo Nishioka; Naoki Sakura; Ken-Ichi Miyamoto
Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, L-Asp-hexapeptide-conjugated estradiol.
Biological & pharmaceutical bulletin 2006;29(6):1229-33.
2006: Mingji Jin; Tsutomu Shimada; Koichi Yokogawa; Masaaki Nomura; Yukio Kato; Akira Tsuji; Ken-ichi Miyamoto
Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
International journal of pharmaceutics 2006;309(1-2):81-6.
2006: Ken-ichi Miyamoto; Tatsuo Nishioka; Yoshihiro Waki; Masaaki Nomura; Hiromu Katsuta; Koichi Yokogawa; Hitoshi Amano
Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on osteoclastogenesis.
Journal of bone and mineral metabolism 2006;24(4):260-5.
2006: Koichi Yokogawa; Akane Ido; Takeshi Kurihara; Yasunari Mano; Masaaki Nomura; Junko Ishizaki; Ken-Ichi Miyamoto
Serum aminotransferase activity as a predictor for estimation of total clearance of hepatically metabolized drugs in rats with acute hepatic failure.
Biological & pharmaceutical bulletin 2006;29(1):141-5.
2005: Satoshi Morito; Kuniko Yaguchi; Mikiko Imada; Chihiro Tachikawa; Masaaki Nomura; Shuzo Moritani; Manabu Igarashi; Koichi Yokogawa; Ken-ichi Miyamoto
Insulin signaling in adipocytes differentiated from mouse stromal MC3T3-G2/PA6 cells.
Biological & pharmaceutical bulletin 2005;28(11):2040-5.
2005: Mingji Jin; Tsutomu Shimada; Miki Shintani; Koichi Yokogawa; Masaaki Nomura; Ken-Ichi Miyamoto
Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.
Drug metabolism and pharmacokinetics 2005;20(5):324-30.
2005: Yasuharu Mizuhara; Yukiho Takizawa; Kazuhisa Ishihara; Takayuki Asano; Hirotaka Kushida; Takashi Morota; Yoshio Kase; Shuichi Takeda; Masaki Aburada; Masaaki Nomura; Koichi Yokogawa
The influence of the sennosides on absorption of glycyrrhetic acid in rats.
Biological & pharmaceutical bulletin 2005;28(10):1897-902.
2005: Masaaki Nomura; Daisuke Ichimatsu; Shuzo Moritani; Ichiko Koyama; Zigang Dong; Koichi Yokogawa; Ken-Ichi Miyamoto
Inhibition of epidermal growth factor-induced cell transformation and Akt activation by caffeine.
Molecular carcinogenesis 2005;44(1):67-76.
2005: Masaaki Nomura; Toshio Matsunami; Kayoko Kobayashi; Tadao Uchibayashi; Kiyoshi Koshida; Motohiro Tanaka; Mikio Namiki; Yasuharu Mizuhara; Tetsuo Akiba; Koichi Yokogawa; Shuzo Moritani; Ken-Ichi Miyamoto
Involvement of ABC transporters in chemosensitivity of human renal cell carcinoma, and regulation of MRP2 expression by conjugated bilirubin.
Anticancer research 2005;25(4):2729-35.
2005: Mingji Jin; Tsutomu Shimada; Koichi Yokogawa; Masaaki Nomura; Yasuharu Mizuhara; Hiroyuki Furukawa; Junko Ishizaki; Ken-Ichi Miyamoto
Cremophor EL releases cyclosporin A adsorbed on blood cells and blood vessels, and increases apparent plasma concentration of cyclosporin A.
International journal of pharmaceutics 2005;293(1-2):137-44.
2005: Tsutomu Shimada; Masaaki Nomura; Koichi Yokogawa; Yoshio Endo; Takuma Sasaki; Ken-ichi Miyamoto; Yutaka Yonemura
Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice.
The Journal of pharmacy and pharmacology 2005;57(2):177-81.
2004: Tetsuo Akiba; Kuniko Yaguchi; Kikue Tsutsumi; Tatsuo Nishioka; Ichiko Koyama; Masaaki Nomura; Koichi Yokogawa; Shuzo Moritani; Ken-ichi Miyamoto
Inhibitory mechanism of caffeine on insulin-stimulated glucose uptake in adipose cells.
Biochemical pharmacology 2004;68(10):1929-37.
2004: Koichi Yokogawa; Mingji Jin; Naho Furui; Masaru Yamazaki; Hiromi Yoshihara; Masaaki Nomura; Hiroyuki Furukawa; Junko Ishizaki; Sachio Fushida; Kouichi Miwa; Ken-ichi Miyamoto
Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles.
The Journal of pharmacy and pharmacology 2004;56(5):629-34.
2004: Masami Kawahara; Hiromi Kagiyama; Yoshimitsu Kanazawa; Hiroyuki Tsuchiya; Katsuro Tomita; Koichi Yokogawa; Ken-ichi Miyamoto
Rapid determination method of caffeine and application to monitoring of caffeine-assisted chemotherapy.
Biopharmaceutics & drug disposition 2004;25(2):61-7.
2004: Koichi Yokogawa; Mao Watanabe; Harunori Takeshita; Masaaki Nomura; Yasunari Mano; Ken-ichi Miyamoto
Serum aminotransferase activity as a predictor of clearance of drugs metabolized by CYP isoforms in rats with acute hepatic failure induced by carbon tetrachloride.
International journal of pharmaceutics 2004;269(2):479-89.
2003: Mitsuo Tamai; Yoshie Ito; Hauka Mirura; Hirotaka Tsukada; Koichi Yokogawa; Masaaki Nomura; Shuzo Moritani; Ken-Ichi Miyamoto
Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells.
Anticancer research 2003;23(6C):4781-7.
2003: Koichi Yokogawa; Yuichiro Shima; Tomoka Hashimoto; Makoto Hiyajyo; Kaori Kadoyama; Junko Ishizaki; Masaaki Nomura; Ken-ichi Miyamoto
High bioavailabilty of alpha-tocopherol loaded into poly (DL-lactic-co-glycolic acid) microspheres in apolipoprotein B knockout mice.
Pharmaceutical research 2003;20(11):1846-50.
2003: Kazumasa Naruhashi; Masaaki Nomura; Hiroyuki Kamei; Shunsuke Ono; Ryo Matsushita; Sakae Shimizu; Koichi Yokogawa; Kiyofumi Yamada; Nagao Suzuki; Ken-ichi Miyamoto; Kazuko Kimura
[Objective evaluation of clinical pharmacy lectures and experience in a master program using visual analog scale method].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2003;123(11):973-80.
2003: Tsutomu Shimada; Yuki Aoki; Koichi Yokogawa; Masaaki Nomura; Junko Ishizaki; Jun Nishigami; Ken-ichi Miyamoto
Influence of cytarabine and cyclophosphamide on the disposition kinetics of cyclosporin A after bone marrow transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(11):788-93.
2003: Hideomi Yamagami; Tatsuo Nishioka; Eiji Ochiai; Kazuyo Fukushima; Masaaki Nomura; Shohei Kasugai; Shuzo Moritani; Koichi Yokogawa; Ken-ichi Miyamoto
Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2.
Biochemical pharmacology 2003;66(5):801-7.
2003: Ken-ichi Miyamoto; Hirokazu Suzuki; Shinya Yamamoto; Yukie Saitoh; Eiji Ochiai; Shuzo Moritani; Koichi Yokogawa; Yoshihiro Waki; Shohei Kasugai; Hiroyuki Sawanishi; Hideomi Yamagami
Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(8):1471-7.
2003: Koichi Yokogawa; Yuichiro Shima; Tomoka Hashimoto; Makoto Hiyajyo; Kaori Kadoyama; Junko Ishizki; Masaaki Nomura; Ken-ichi Miyamoto
Disposition kinetics of alpha-tocopherol in apolipoprotein B knockout mice.
Pharmaceutical research 2003;20(3):368-72.
2002: Tsutomu Shimada; Ai Terada; Koichi Yokogawa; Hiroko Kaneko; Masaaki Nomura; Kyosuke Kaji; Shuichi Kaneko; Ken-Ichi Kobayashi; Ken-Ichi Miyamoto
Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy.
Transplantation 2002;74(10):1419-24.
2002: Sachio Fushida; Nao Furui; Shinichi Kinami; Itasu Ninomiya; Takashi Fujimura; Genichi Nishimura; Tetsuo Ohta; Koichi Yokogawa; Kenichi Miyamoto; Koichi Miwa
[Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination].
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(12):2164-7.
2002: Sachio Fushida; Furui Nao; Shinichi Kinami; Itasu Ninomiya; Takashi Fujimura; Genichi Nishimura; Tetsuo Ohta; Koichi Yokogawa; Kenichi Miyamoto; Koichi Miwa
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(10):1759-63.
2002: Mariko Asahi; Ryo Matsushita; Masami Kawahara; Tomoyuki Ishida; Chie Emoto; Nagao Suzuki; Osamu Kataoka; Chisato Mukai; Miyoji Hanaoka; Junko Ishizaki; Koichi Yokogawa; Ken'ichi Miyamoto
Causative agent of vascular pain among photodegradation products of dacarbazine.
The Journal of pharmacy and pharmacology 2002;54(8):1117-22.
2002: Yoshie Itoh; Mitsuo Tamai; Koichi Yokogawa; Masaaki Nomura; Shuzo Moritani; Hiroshi Suzuki; Yuichi Sugiyama; Ken-ichi Miyamoto
Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells.
Anticancer research 2002;22(3):1649-53.
2002: Koichi Yokogawa; Junko Ishizaki; Shoji Ohkuma; Ken-ichi Miyamoto
Influence of lipophilicity and lysosomal accumulation on tissue distribution kinetics of basic drugs: a physiologically based pharmacokinetic model.
Methods and findings in experimental and clinical pharmacology 2002;24(2):81-93.
2002: Koichi Yokogawa; Tsutomu Shimada; Yasuhiko Higashi; Yoshie Itoh; Toshiko Masue; Junko Ishizaki; Mariko Asahi; Ken-ichi Miyamoto
Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
Biochemical pharmacology 2002;63(4):777-83.
2002: Minori Odanaka; Mariko Asahi; Koichi Yokogawa; Ken-ichi Miyamoto
[Investigation of actual use of laxatives and application to the active drug information offer in drug control guidance].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2002;122(1):89-95.
2001: Koichi Yokogawa; T Nakaharu; Junko Ishizaki; Eijiro Ozaki; Y Takeda; H Mabuchi; Ryo Matsushita; Kazuko Kimura; E Nakashima; F Ichimura; Ken-ichi Miyamoto
Kinetic phenotypic diagnosis of N-acetylation polymorphism in patients based on ratio of urinary metabolites of salicylazosulfapyridine.
International journal of pharmaceutics 2001;229(1-2):183-91.
2001: Koichi Yokogawa; S Iwashita; A Kubota; Y Sasaki; Junko Ishizaki; M Kawahara; Ryo Matsushita; Kazuko Kimura; F Ichimura; Ken-ichi Miyamoto
Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits.
Pharmaceutical research 2001;18(9):1320-6.
2001: Junko Ishizaki; Koichi Yokogawa; Shoji Ohkuma; F Ichimura; Ken-ichi Miyamoto
[Studies on the mechanism of subcellular distribution of basic drugs based on their lipophilicity].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2001;121(7):557-65.
2001: Toru Sekido; N Sakura; Y Higashi; K Miya; Y Nitta; Masaaki Nomura; Hiroyuki Sawanishi; Keiko Morito; Yukito Masamune; Shohei Kasugai; Koichi Yokogawa; Ken-ichi Miyamoto
Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential.
Journal of drug targeting 2001;9(2):111-21.
2001: Y Higashi; Koichi Yokogawa; N Takeuchi; Ikumi Tamai; Masaaki Nomura; Nobuo Hashimoto; JI Hayakawa; Ken-ichi Miyamoto; Akira Tsuji
Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice.
The Journal of pharmacy and pharmacology 2001;53(4):527-33.
2001: Koichi Yokogawa; K Miya; Toru Sekido; Y Higashi; Masaaki Nomura; R Fujisawa; Keiko Morito; Yukito Masamune; Yoshihiro Waki; Shohei Kasugai; Ken-ichi Miyamoto
Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice.
Endocrinology 2001;142(3):1228-33.
2001: H Suzuki; Hiroyuki Sawanishi; K Yamamoto; Koichi Yokogawa; K Miyamoto
Phosphodiesterase 4 isoenzyme inhibitory activity of 3-phenylxanthines and 4-pheny.
Chemical & pharmaceutical bulletin 2001;49(2):188-91.
2000: Junko Ishizaki; Koichi Yokogawa; F Ichimura; Shoji Ohkuma
Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs.
The Journal of pharmacology and experimental therapeutics 2000;294(3):1088-98.
1999: T Minamino; Mitsuo Tamai; Yoshie Itoh; Y Tatsumi; Masaaki Nomura; Koichi Yokogawa; H Suzuki; Y Sugiyama; T Ohshima; Ken-ichi Miyamoto
In vivo cisplatin resistance depending upon canalicular multispecific organic anion transporter (cMOAT).
Japanese journal of cancer research : Gann 1999;90(10):1171-8.
1999: Koichi Yokogawa; M Yonekawa; Ikumi Tamai; Rikiya Ohashi; Y Tatsumi; Y Higashi; Masaaki Nomura; Nobuo Hashimoto; Hiroko Nikaido; JI Hayakawa; Jun-ichi Nezu; A Oku; Miyuki Shimane; Ken-ichi Miyamoto; Akira Tsuji
Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice.
Hepatology (Baltimore, Md.) 1999;30(4):997-1001.
1999: Koichi Yokogawa; K Miya; Ikumi Tamai; Y Higashi; Masaaki Nomura; Ken-ichi Miyamoto; Akira Tsuji
Characteristics of L-carnitine transport in cultured human hepatoma HLF cells.
The Journal of pharmacy and pharmacology 1999;51(8):935-40.
1999: Koichi Yokogawa; M Takahashi; Ikumi Tamai; H Konishi; Masaaki Nomura; Shuzo Moritani; Ken-ichi Miyamoto; Akira Tsuji
P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice.
Pharmaceutical research 1999;16(8):1213-8.
1999: Koichi Yokogawa; Y Higashi; Ikumi Tamai; Masaaki Nomura; Nobuo Hashimoto; Hiroko Nikaido; JI Hayakawa; Ken-ichi Miyamoto; Akira Tsuji
Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
The Journal of pharmacology and experimental therapeutics 1999;289(1):224-30.
1998: Junko Ishizaki; Koichi Yokogawa; E Nakashima; Shoji Ohkuma; F Ichimura
Uptake of basic drugs into rat lung granule fraction in vitro.
Biological & pharmaceutical bulletin 1998;21(8):858-61.
1998: Junko Ishizaki; Koichi Yokogawa; E Nakashima; Shoji Ohkuma; F Ichimura
Influence of ammonium chloride on the tissue distribution of anticholinergic drugs in rats.
The Journal of pharmacy and pharmacology 1998;50(7):761-6.
1998: Junko Ishizaki; Koichi Yokogawa; E Nakashima; Tatsunori Takayasu; T Ohshima; F Ichimura
Effect of sequence of administration on the pharmacokinetic interaction between the anticholinergic drug biperiden and [3H]quinuclidinyl benzylate or [3H]N-methylscopolamine in rats.
The Journal of pharmacy and pharmacology 1998;50(2):189-96.
1998: Junko Ishizaki; Koichi Yokogawa; E Nakashima; Shoji Ohkuma; F Ichimura
Characteristic subcellular distribution, in brain, heart and lung, of biperiden, trihexyphenidyl, and (-)-quinuclidinyl benzylate in rats.
Biological & pharmaceutical bulletin 1998;21(1):67-71.
1997: Junko Ishizaki; Koichi Yokogawa; E Nakashima; F Ichimura
Relationships between the hepatic intrinsic clearance or blood cell-plasma partition coefficient in the rabbit and the lipophilicity of basic drugs.
The Journal of pharmacy and pharmacology 1997;49(8):768-72.
1997: Junko Ishizaki; Koichi Yokogawa; E Nakashima; F Ichimura
Prediction of changes in the clinical pharmacokinetics of basic drugs on the basis of octanol-water partition coefficients.
The Journal of pharmacy and pharmacology 1997;49(8):762-7.
1996: Junko Ishizaki; Koichi Yokogawa; M Hirano; E Nakashima; Yoshimichi Sai; Shoji Ohkuma; T Ohshima; F Ichimura
Contribution of lysosomes to the subcellular distribution of basic drugs in the rat liver.
Pharmaceutical research 1996;13(6):902-6.
1994: T Sumiyoshi; H Kido; H Sakamoto; K Urasaki; K Suzuki; N Yamaguchi; Hiroshi Mori; K Shiba; Koichi Yokogawa
In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
Pharmacology, biochemistry, and behavior 1994;47(3):553-7.
1993: E Nakashima; Junko Ishizaki; M Takeda; R Matsushita; Koichi Yokogawa; F Ichimura
Pharmacokinetics of anticholinergic drugs and brain muscarinic receptor alterations in streptozotocin diabetic rats.
Biopharmaceutics & drug disposition 1993;14(8):673-84.
1993: T Sumiyoshi; H Kido; H Sakamoto; K Urasaki; K Suzuki; N Yamaguchi; H Mori; K Shiba; Koichi Yokogawa; F Ichimura
Time course of dopamine-D2 and serotonin-5-HT2 receptor occupancy rates by haloperidol and clozapine in vivo.
The Japanese journal of psychiatry and neurology 1993;47(1):131-7.
1992: Junko Ishizaki; E Nakashima; Koichi Yokogawa; T Nagano; T Takayasu; F Ichimura
A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats.
Drug metabolism and disposition: the biological fate of chemicals 1992;20(4):485-9.
1992: Koichi Yokogawa; E Nakashima; Junko Ishizaki; M Hasegawa; H Kido; F Ichimura
Brain regional pharmacokinetics of biperiden in rats.
Biopharmaceutics & drug disposition 1992;13(2):131-40.
1990: Koichi Yokogawa; E Nakashima; Junko Ishizaki; H Maeda; T Nagano; F Ichimura
Relationships in the structure-tissue distribution of basic drugs in the rabbit.
Pharmaceutical research 1990;7(7):691-6.
1990: Koichi Yokogawa; E Nakashima; F Ichimura
Effect of fat tissue volume on the distribution kinetics of biperiden as a function of age in rats.
Drug metabolism and disposition: the biological fate of chemicals 1990;18(2):258-63.
1987: F Ichimura; Y Deguchi; Koichi Yokogawa; E Nakashima
The effects of valproate on plasma concentration of phenytoin in normal and D-galactosamine-treated rats.
Chemical & pharmaceutical bulletin 1987;35(5):2030-7.
1987: E Nakashima; Koichi Yokogawa; F Ichimura; K Kurata; H Kido; N Yamaguchi; T Yamana
A physiologically based pharmacokinetic model for biperiden in animals and its extrapolation to humans.
Chemical & pharmaceutical bulletin 1987;35(2):718-25.
1987: E Nakashima; Koichi Yokogawa; F Ichimura; T Hashimoto; T Yamana; A Tsuji
Effects of fasting on biperiden pharmacokinetics in the rat.
Journal of pharmaceutical sciences 1987;76(1):10-3.
1986: Koichi Yokogawa; E Nakashima; F Ichimura; T Yamana
Fundamental pharmacokinetic properties of biperiden: tissue distribution and elimination in rabbits.
Journal of pharmacobio-dynamics 1986;9(4):409-16.
1985: Koichi Yokogawa; E Nakashima; F Ichimura; T Yamana
Simultaneous microdetermination of biperiden, haloperidol, and trihexyphenidyl in plasma and its application to pharmacokinetic analysis after concomitant intravenous administration of the drugs to rabbits.
Chemical & pharmaceutical bulletin 1985;33(10):4581-6.